trending Market Intelligence /marketintelligence/en/news-insights/trending/clUlGS-phRkqYlYvnnX4wA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Purdue Pharma settles Okla. opioid lawsuit for $270M

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Purdue Pharma settles Okla. opioid lawsuit for $270M

Purdue Pharma LP has settled with the state of Oklahoma for $270 million in a lawsuit that alleged the Connecticut drugmaker's advertising fueled the U.S. opioid epidemic.

Oklahoma Attorney General Mike Hunter brought the lawsuit against OxyContin-maker Purdue, as well as Johnson & Johnson and Teva Pharmaceutical Industries Ltd. and other defendants in 2017 seeking more than $20 billion in damages.

The settlement only covers Purdue. For the other defendants, a trial is set for May 28 that will mark the first of about 2,000 lawsuits regarding the opioids crisis in the U.S. The Oklahoma Supreme Court on March 25 rejected the companies' efforts to delay the trial.

Hunter said during a March 26 press conference that although many factors led to the settlement, the attorney general's office "took into account that [Purdue was] modeling bankruptcy."

Reports from earlier in March said Purdue is considering filing for Chapter 11 bankruptcy protection, although the privately held company has neither confirmed or denied the news.

Hunter said nearly $200 million of the settlement will help fund an addiction treatment center at Oklahoma State University. The center's current annual budget, as estimated by OSU President of Health Sciences Kayse Shrum at the press conference, is $2.4 million.

Beyond the endowment, the state will also receive $12.5 million to address the epidemic in the state and another $60 million to offset legal fees.

Although Purdue's owners, the Sackler family, have been named in several lawsuits involving opioid marketing, they were not mentioned in Oklahoma's suit.